Persistent URL of this record https://hdl.handle.net/1887/120634
In Collections
This item can be found in the following collections:
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
- All authors
- Ferrari, M.D.; Diener, H.C.; Ning, X.P.; Galic, M.; Cohen, J.M.; Yang, R.H.; Mueller, M.; Ahn, A.H.; Schwartz, Y.C.; Grozinski-Wolff, M.; Janka, L.; Ashina, M.
- Date
- 2019-09-21
- Journal
- Lancet
- Volume
- 394
- Issue
- 10203
- Pages
- 1030 - 1040